(a)The Board shall promulgate specific guidelines
for dentists for the responsible prescribing of opioids, benzodiazepines,
barbiturates, or carisoprodol.
(b)The Board shall periodically access a dentist's
prescription information through the Texas State Board of Pharmacy's
Prescription Monitoring Program to determine whether the dentist is
engaging in potentially harmful prescribing patterns or practices.
This determination will be based on:
(1)the number of times a dentist prescribes opioids,
benzodiazepines, barbiturates, or carisoprodol; and
(2)patterns of prescribing combinations of those drugs
and other dangerous combinations identified by the Texas State Board
of Pharmacy.
(c)The Board shall notify a dentist if the agency
discovers that the dentist may be engaging in potentially harmful
prescribing patterns or practices.
(d)The Board may initiate an investigation of a dentist
if the agency finds evidence during a periodic check that the dentist
is engaging in conduct that violates any laws or rules related to
the practice of dentistry.
The agency certifies that legal counsel has reviewed
the proposal and found it to be within the state agency's legal authority
to adopt.
Filed with the Office
of the Secretary of State on September 29, 2017
TRD-201703947 Kelly Parker
Executive Director
State Board of Dental Examiners
Earliest possible date of adoption: November 12, 2017
For further information, please call: (512) 475-0977
|